ACI Donates 500,000 N95 Respirators to Project N95

Masks to be distributed to communities in need across country

National not-for-profit 501(c) (3) group Project N95 announced on Tuesday that medical device manufacturer Advanced Concept Innovations (ACI) of Lakeland Florida has donated 500,000 N95 respirators to be distributed to communities in need across the country. These N95 respirators – the gold standard in respiratory protection- will be distributed through local non-profit organizations.

Initial shipments of N95s are going to the Louisiana Primary Care Association and a tribal mutual aid society in the Midwest.

“Throughout this pandemic our focus has been on protecting healthcare workers and our general population by providing an affordable, quality American-made N95 for as many Americans as possible. We consider it an honor to be able to partner with Project N95 because we share its vision that every person should have affordable, quality protection. Our employees are happy to share the efforts of our hard work to protect other Americans, especially the healthcare workers who have sacrificed so much,” said Matt Muller, President of ACI.

“Project N95 is pleased to partner with ACI and is grateful for the very generous contribution of 500,000 masks for communities in need across the country. Our mission is to make sure everyone has access for affordable, quality respiratory protection and this donation will help protect people in communities across the United States,” said Anne Miller, Executive Director of Project N95.

For more information or assistance purchasing PPE and tests, please visit https://shop.projectn95.org.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”